RSS-Feed abonnieren
DOI: 10.1055/s-0037-1603009
Globotriaosylsphingosine (Lyso-GB3 bzw. Lyso-GL3), an Excellent Biomarker for Children with Fabry Disease
Publikationsverlauf
Publikationsdatum:
26. April 2017 (online)
Introduction: Fabry disease (FD) is an X-linked disorder that affects both males and females and is caused by deficient activity of the lysosomal enzyme a-galactosidase A (a-Gal A).1 This leads to the accumulation of globotriaosylceramide (GL-3, Gb3), predominantly in the lysosomes of multiple cell types, and the elevation of globotriaosylsphingosine (lyso-GL-3, lyso-Gb3), the more water-soluble deacylated form of GL-3, in the plasma.2
Start |
6 Mo |
12 Mo |
|
Index patient |
127 |
8.6 |
4.6 |
Brother |
128 |
125 |
127 |
Mother |
46 |
48 |
52 |
Uncle |
86 |
42 |
39 |
Case Series We report a very interesting Fabry family with and without enzyme replacement therapy ([Table 1]).
Conclusion: Lyso-GB3 is an excellent marker for classic Fabry disease, especially for an excellent prognostic marker for Fabry children.
-
Reference
- 1 Germain DP.. Fabry disease. Orphanet J Rare Dis 201;5:30. doi: 10.1186/1750-1172-5-30
- 2 Aerts JM, Groener JE, Kuiper S. , et al. Elevated globotriaosylsphingosine is a hallmark of Fabry disease. Proc Natl Acad Sci U S A 2008; 105 (08) 2812-2817